A prospective longitudinal study evaluating the usefulness of the interferon-gamma releasing assay for predicting active tuberculosis in allogeneic hematopoietic stem cell transplant recipients

Journal of Infection

Volumn 69, Issue 2, 2014, Pages 165-173

  Lee, Yu Mi ^a,b   Lee, Sang Oh ^a   Choi, Sang Ho ^a   Kim, Yang Soo ^a   Woo, Jun Hee ^a   Kim, Dae Young ^a   Lee, Jung Hee ^a   Lee, Je Hwan ^a   Lee, Kyoo Hyung ^a   Kim, Sung Han ^a  

^a University of Ulsan College of Medicine   (South Korea)

^b Inje University College of Medicine   (South Korea)

Author keywords

Hematopoietic stem cell transplant; Interferon gamma releasing assay; Tuberculosis

Indexed keywords

ADENOSINE DEAMINASE; ISONIAZID; GAMMA INTERFERON;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; APLASTIC ANEMIA; ARTICLE; BACTERIUM CULTURE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GRAFT RECIPIENT; HUMAN; INCIDENCE; LATENT TUBERCULOSIS; LONGITUDINAL STUDY; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MILIARY TUBERCULOSIS; MORTALITY; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS TEST KIT; MYELODYSPLASTIC SYNDROME; OBSERVATIONAL STUDY; ONSET AGE; PERICARDIAL EFFUSION; PLEURA EFFUSION; PREDICTION; PROSPECTIVE STUDY; TREATMENT RESPONSE; TUBERCULIN TEST; TUBERCULOSIS; TUBERCULOUS PERICARDITIS; TUBERCULOUS PERITONITIS; TUBERCULOUS PLEURISY; BLOOD; FOLLOW UP; HEMATOPOIETIC STEM CELL; IMMUNOLOGY; INTERFERON GAMMA RELEASE ASSAY; PROCEDURES;

ADULT; FEMALE; FOLLOW-UP STUDIES; HEMATOPOIETIC STEM CELLS; HUMANS; INTERFERON-GAMMA; INTERFERON-GAMMA RELEASE TESTS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TRANSPLANT RECIPIENTS; TUBERCULIN TEST; TUBERCULOSIS;

EID: 84903469579     PISSN: 01634453     EISSN: 15322742     Source Type: Journal    
DOI: 10.1016/j.jinf.2014.02.019     Document Type: Article

References (42)

1. Roy V., Weisdorf D. Mycobacterial infections following bone marrow transplantation: a 20 year retrospective review. Bone Marrow Transplant 1997, 19:467-470.
2. Arslan O., Gurman G., Dilek I., Ozcan M., Koc H., Ilhan O., et al. Incidence of tuberculosis after bone marrow transplantation in a single center from Turkey. Haematol (Budap) 1998, 29:59-62.
3. Ip M.S., Yuen K.Y., Woo P.C., Luk W.K., Tsang K.W., Lam W.K., et al. Risk factors for pulmonary tuberculosis in bone marrow transplant recipients. Am J Respir Crit Care Med 1998, 158:1173-1177.
4. Yoo J.H., Lee D.G., Choi S.M., Choi J.H., Park Y.H., Kim Y.J., et al. Infectious complications and outcomes after allogeneic hematopoietic stem cell transplantation in Korea. Bone Marrow Transplant 2004, 34:497-504.
5. Hughes W.T. Mycobacterial infections in bone marrow transplant recipients. Biol Blood Marrow Transplant 2000, 6:359-360.
6. Akan H., Arslan O., Akan O.A. Tuberculosis in stem cell transplant patients. J Hosp Infect 2006, 62:421-426.
7. de la Camara R., Martino R., Granados E., Rodriguez-Salvanes F.J., Rovira M., Cabrera R., et al. Tuberculosis after hematopoietic stem cell transplantation: incidence, clinical characteristics and outcome. Spanish Group on Infectious Complications in Hematopoietic Transplantation. Bone Marrow Transplant 2000, 26:291-298.
8. Yuen K.Y., Woo P.C. Tuberculosis in blood and marrow transplant recipients. Hematol Oncol 2002, 20:51-62.
9. Kim S.H., Song K.H., Choi S.J., Kim H.B., Kim N.J., Oh M.D., et al. Diagnostic usefulness of a T-cell-based assay for extrapulmonary tuberculosis in immunocompromised patients. Am J Med 2009, 122:189-195.
10. Mazurek G.H., Jereb J., Vernon A., LoBue P., Goldberg S., Castro K. Updated guidelines for using Interferon Gamma Release Assays to detect Mycobacterium tuberculosis infection - United States, 2010. MMWR Recomm Rep 2010, 59:1-25.
11. Bakir M., Millington K.A., Soysal A., Deeks J.J., Efee S., Aslan Y., et al. Prognostic value of a T-cell-based, interferon-gamma biomarker in children with tuberculosis contact. Ann Intern Med 2008, 149:777-787.
12. Rangaka M.X., Wilkinson K.A., Glynn J.R., Ling D., Menzies D., Mwansa-Kambafwile J., et al. Predictive value of interferon-γ release assays for incident active tuberculosis: a systematic review and meta-analysis. Lancet Infect Dis 2012, 12:45-55.
13. Diel R., Loddenkemper R., Niemann S., Meywald-Walter K., Nienhaus A. Negative and positive predictive value of a whole-blood interferon-γ release assay for developing active tuberculosis: an update. Am J Respir Crit Care Med 2011, 183:88-95.
14. Singh N., Paterson D.L. Mycobacterium tuberculosis infection in solid-organ transplant recipients: impact and implications for management. Clin Infect Dis 1998, 27:1266-1277.
15. Kang Y.A., Lee H.W., Yoon H.I., Cho B., Han S.K., Shim Y.S., et al. Discrepancy between the tuberculin skin test and the whole-blood interferon gamma assay for the diagnosis of latent tuberculosis infection in an intermediate tuberculosis-burden country. JAMA 2005, 293:2756-2761.
16. Jensen P.A., Lambert L.A., Iademarco M.F., Ridzon R. Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care settings, 2005. MMWR Recomm Rep 2005, 54:1-141.
17. Moreno S., Baraia-Etxaburu J., Bouza E., Parras F., Perez-Tascon M., Miralles P., et al. Risk for developing tuberculosis among anergic patients infected with HIV. Ann Intern Med 1993, 119:194-198.
18. Subramanian A.K., Morris M.I. Mycobacterium tuberculosis infections in solid organ transplantation. Am J Transplant 2013, 13(Suppl. 4):68-76.
19. Bumbacea D., Arend S.M., Eyuboglu F., Fishman J.A., Goletti D., Ison M., et al. The risk of tuberculosis in transplant candidates and recipients: a TBNET consensus statement. Eur Respir J 2012, 40:990-1013.
20. Bowden RA. Typical and atypical mycobacterium infections after hematopoietic stem cell or solid organ transplantation. Transplant infections. 3rd ed.; Lippincott Williams & Wilkins. Philadelphia, PA. p. 232-94.
21. Lalvani A., Pareek M. A 100 year update on diagnosis of tuberculosis infection. Br Med Bull 2010, 93:69-84.
22. Moon S.M., Lee S.O., Choi S.H., Kim Y.S., Woo J.H., Yoon D.H., et al. Comparison of the QuantiFERON-TB Gold In-Tube test with the tuberculin skin test for detecting latent tuberculosis infection prior to hematopoietic stem cell transplantation. Transpl Infect Dis 2013, 15:104-109.
23. Sester U., Wilkens H., van Bentum K., Singh M., Sybrecht G.W., Schafers H.J., et al. Impaired detection of Mycobacterium tuberculosis immunity in patients using high levels of immunosuppressive drugs. Eur Respir J 2009, 34:702-710.
24. Millington K.A., Fortune S.M., Low J., Garces A., Hignley-Wilson S.M., Wickremasinghe M., et al. Rv3615c is a highly immunodominant RD1 (Region of Difference 1)-dependent secreted antigen specific for Mycobacterium tuberculosis infection. Proc Natl Acad Sci U S A 2011, 108:5730-5735.
25. Hougardy J.M., Schepers K., Place S., Drowart A., Lechevin V., Verscheure V., et al. Heparin-binding-hemagglutinin-induced IFN-gamma releasing as a diagnostic tool for latent tuberculosis. PLoS One 2007, 2:e926.
26. Goletti D., Butera O., Vanini V., Lauria F.N., Lange C., Franken K.L., et al. Response to Rv2628 latency antigen associates with cured tuberculosis and remote infection. Eur Respir J 2010, 36:135-142.
27. Ruhwald M., Bodmer T., Maier C., Jepsen M., Haaland M.B., Eugen-Olsen J., et al. Evaluating the potential of IP-10 and MCP-2 as biomarkers for the diagnosis of tuberculosis. Eur Respir J 2008, 32:1607-1615.
28. Biselli R., Mariotti S., Sargentini V., Sauzullo I., Lastilla M., Mengoni F., et al. Detection of interleukin-2 in addition to interferon-gamma discriminates active tuberculosis patients, latently infected individuals, and controls. Clin Microbiol Infect 2010, 16:1282-1284.
29. Goletti D., Raja A., Ahamed Kabeer B.S., Rodrigues C., Sodha A., Butera O., et al. IFN-gamma, but not IP-10, MCP-2 or IL-2 response to RD1 selected peptides associates to active tuberculosis. J Infect 2010, 61:133-143.
30. Harari A., Rozot V., Enders F.B., Perreau M., Stalder J.M., Nicod L.P., et al. Dominant TNF-α+ Mycobacterium tuberculosis-specific CD4+ T cell responses discriminate between latent infection and active disease. Nat Med 2011, 17:372-376.
31. Petruccioli E., Petrone L., Vanini V., Sampaolesi A., Gualano G., Girardi E., et al. IFNγ/TNFα specific-cells and effector memory phenotype associate with active tuberculosis. J Infect 2013, 66:475.
32. Diel R., Goletti D., Ferrara G., Bothamley G., Cirillo D., Kampmann B., et al. Interferon-γ release assays for the diagnosis of latent Mycobacterium tuberculosis infection: a systematic review and meta-analysis. Eur Respir J 2011, 37:88-99.
33. Jonnalagadda S., Lohman Payne B., Brown E., Wamalwa D., Maleche Obimbo E., Majiwa M., et al. Latent tuberculosis detection by interferon γ release assay during pregnancy predicts active tuberculosis and mortality in human immunodeficiency virus type 1-infected women and their children. J Infect Dis 2010, 202:1826-1835.
34. Aichelburg M.C., Rieger A., Breitenecker F., Pfistershammer K., Tittes J., Eltz S., et al. Detection and prediction of active tuberculosis disease by a whole-blood interferon-gamma release assay in HIV-1-infected individuals. Clin Infect Dis 2009, 48:954-962.
35. Aichelburg M.C., Reiberger T., Breitenecker F., Mandorfer M., Makristathis A., Rieger A. Reversion and conversion of interferon-γ releasing assay results in HIV-1-infected individuals. J Infect Dis 2014, 209:729-733.
36. Scrivo R., Sauzullo I., Mengoni F., Priori R., Coppola M., Laiani G., et al. Mycobacterial interferon-γ release variations during longterm treatment with tumor necrosis factor blockers: lack of correlation with clinical outcome. J Rheumatol 2013, 40:157-165.
37. Scrivo R., Sauzullo I., Mengoni F., Iaiani G., Vestri A.R., Priori R., et al. Serial interferon-γ release assays for screening and monitoring of tuberculosis infection during treatment with biologic agents. Clin Rheumatol 2012, 31:1567-1575.
38. Kim S.H., Lee S.O., Park J.B., Park I.A., Park S.J., Yun S.C., et al. A prospective longitudinal study evaluating the usefulness of a T-cell-based assay for latent tuberculosis infection in kidney transplant recipients. Am J Transplant 2011, 11:1927-1935.
39. Lopez de Castilla D., Schluger N.W. Tuberculosis following solid organ transplantation. Transpl Infect Dis 2010, 12:106-112.
40. Torre-Cisneros J., Doblas A., Aguado J.M., San Juan R., Blanes M., Montejo M., et al. Tuberculosis after solid-organ transplant: incidence, risk factors, and clinical characteristics in the RESITRA (Spanish Network of Infection in Transplantation) cohort. Clin Infect Dis 2009, 48:1657-1665.
41. Munoz P., Rodriguez C., Bouza E. Mycobacterium tuberculosis infection in solid organ transplantations. Clin Infect Dis 2005, 40:581-587.
42. Whalen C.C., Johnson J.L., Okwera A., Hom D.L., Huebner R., Mugyenyi P., et al. A trial of three regimens to prevent tuberculosis in Ugandan adults infected with the human immunodeficiency virus, Uganda-Case Western Reserve University Research Collaboration. N Engl J Med 1997, 337:801-808.